Article Figures & Data
Figures
- FIG 1.
Delphi methodology as it was used in this article.
- FIG 2.
Summary of the results of the Delphi consensus panel. The asterisk means see Table 1 for dosages. Two asterisks mean see Table 2 for dosages.
Tables
Agent Tirofiban Eptifibatide Abciximab Loading dose (IV or IA bolus) 12 mcg/kg for 30 minb 180 mcg/kg for 1–2 min 0.25 mg/kg Maintenance dose (if necessary, IV infusion for 12–24 h) 0.1 mcg/kg/min 2 mcg/min 125 mcg/kg/min Trade name Aggrastat Integrilin ReoPro Duration of antiplatelet effect 4–8 h 4 h 48 h
Jump to section
Related Articles
Cited By...
- Is intraprocedural intravenous aspirin safe for patients who require emergent extracranial stenting during mechanical thrombectomy?
- Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update
- Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update
- Antithrombotic therapies for neurointerventional surgery: a 2021 French comprehensive national survey
- Management and outcome of patients with acute ischemic stroke and tandem carotid occlusion in the ESCAPE-NA1 trial